These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24321005)

  • 21. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
    Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
    No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
    Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
    J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
    Carmant L
    Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vigabatrin for the treatment of infantile spasms: final report of a randomized trial.
    Elterman RD; Shields WD; Bittman RM; Torri SA; Sagar SM; Collins SD
    J Child Neurol; 2010 Nov; 25(11):1340-7. PubMed ID: 20404353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vigabatrin as first line therapy in infantile spasms: review of seven patients.
    Kwong L
    J Paediatr Child Health; 1997 Apr; 33(2):121-4. PubMed ID: 9145354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
    Ohtsuka Y
    Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
    Hancock E; Osborne JP
    J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case report on the efficacy of vigabatrin analogue (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115) in a patient with infantile spasms.
    Doumlele K; Conway E; Hedlund J; Tolete P; Devinsky O
    Epilepsy Behav Case Rep; 2016; 6():67-9. PubMed ID: 27668180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.
    Vigevano F; Cilio MR
    Epilepsia; 1997 Dec; 38(12):1270-4. PubMed ID: 9578521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
    Jambaqué I; Chiron C; Dumas C; Mumford J; Dulac O
    Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
    Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pulse rapamycin therapy for infantile spasms and associated cognitive decline.
    Raffo E; Coppola A; Ono T; Briggs SW; Galanopoulou AS
    Neurobiol Dis; 2011 Aug; 43(2):322-9. PubMed ID: 21504792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling new therapies for infantile spasms.
    Chudomelova L; Scantlebury MH; Raffo E; Coppola A; Betancourth D; Galanopoulou AS
    Epilepsia; 2010 Jul; 51 Suppl 3(Suppl 3):27-33. PubMed ID: 20618396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current role of vigabatrin in infantile spasms.
    Parisi P; Bombardieri R; Curatolo P
    Eur J Paediatr Neurol; 2007 Nov; 11(6):331-6. PubMed ID: 17625936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.
    Yum MS; Lee EH; Ko TS
    J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of infantile spasms.
    Hancock E; Osborne JP; Milner P
    Cochrane Database Syst Rev; 2002; (2):CD001770. PubMed ID: 12076419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.